United-Guardian (NASDAQ:UG) Coverage Initiated by Analysts at StockNews.com

Analysts at StockNews.com initiated coverage on shares of United-Guardian (NASDAQ:UG) in a research note issued to investors on Friday. The firm set a “buy” rating on the stock.

United-Guardian Stock Up 2.7 %

Shares of NASDAQ UG opened at $9.20 on Friday. The stock’s 50 day moving average price is $10.35 and its two-hundred day moving average price is $11.33. United-Guardian has a 52-week low of $7.35 and a 52-week high of $16.25. The stock has a market capitalization of $42.26 million, a P/E ratio of 12.11 and a beta of 0.73.

United-Guardian (NASDAQ:UG) last posted its quarterly earnings results on Friday, March 21st. The company reported $0.11 earnings per share (EPS) for the quarter. The business had revenue of $2.48 million for the quarter. United-Guardian had a return on equity of 30.25% and a net margin of 28.30%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC lifted its position in United-Guardian by 8.3% in the 3rd quarter. Geode Capital Management LLC now owns 28,335 shares of the company’s stock valued at $450,000 after purchasing an additional 2,170 shares during the last quarter. Heron Bay Capital Management bought a new position in United-Guardian in the 4th quarter worth about $135,000. Renaissance Technologies LLC increased its stake in shares of United-Guardian by 4.3% in the fourth quarter. Renaissance Technologies LLC now owns 190,163 shares of the company’s stock valued at $1,818,000 after purchasing an additional 7,800 shares during the period. United Capital Financial Advisors LLC bought a new stake in shares of United-Guardian during the fourth quarter valued at approximately $192,000. Finally, Northern Trust Corp boosted its position in shares of United-Guardian by 69.5% during the fourth quarter. Northern Trust Corp now owns 25,527 shares of the company’s stock worth $244,000 after buying an additional 10,466 shares during the period. Institutional investors and hedge funds own 23.16% of the company’s stock.

About United-Guardian

United-Guardian, Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries.